Zurich Cantonal Bank’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $19.3K | Buy |
3,161
+1,418
| +81% | +$9.26K | ﹤0.01% | 2482 |
|
|
2026
Q1 | $12K | Buy |
+1,743
| New | +$13.4K | ﹤0.01% | 2476 |
|
|
2023
Q4 | – | Sell |
-7,342
| Closed | -$31.7K | – | 2789 |
|
|
2023
Q3 | $31.7K | Hold |
7,342
| – | – | ﹤0.01% | 2670 |
|
|
2023
Q2 | $48.4K | Hold |
7,342
| – | – | ﹤0.01% | 2625 |
|
|
2023
Q1 | $49.9K | Hold |
7,342
| – | – | ﹤0.01% | 2597 |
|
|
2022
Q4 | $54.3K | Hold |
7,342
| – | – | ﹤0.01% | 2574 |
|
|
2022
Q3 | $73K | Hold |
7,342
| – | – | ﹤0.01% | 2433 |
|
|
2022
Q2 | $80K | Hold |
7,342
| – | – | ﹤0.01% | 2382 |
|
|
2022
Q1 | $83K | Hold |
7,342
| – | – | ﹤0.01% | 2358 |
|
|
2021
Q4 | $115K | Buy |
7,342
+1,606
| +28% | +$28K | ﹤0.01% | 2429 |
|
|
2021
Q3 | $98K | Buy |
+5,736
| New | +$100K | ﹤0.01% | 2353 |
|
|
2021
Q1 | – | Sell |
-9,575
| Closed | -$126K | – | 2607 |
|
|
2020
Q4 | $126K | Hold |
9,575
| – | – | ﹤0.01% | 2111 |
|
|
2020
Q3 | $92K | Hold |
9,575
| – | – | ﹤0.01% | 2027 |
|
|
2020
Q2 | $110K | Buy |
9,575
+5,699
| +147% | +$64.5K | ﹤0.01% | 1898 |
|
|
2020
Q1 | $40K | Hold |
3,876
| – | – | ﹤0.01% | 2046 |
|
|
2019
Q4 | $64K | Hold |
3,876
| – | – | ﹤0.01% | 2003 |
|
|
2019
Q3 | $51K | Hold |
3,876
| – | – | ﹤0.01% | 2034 |
|
|
2019
Q2 | $55K | Hold |
3,876
| – | – | ﹤0.01% | 2000 |
|
|
2019
Q1 | $71K | Buy |
3,876
+21
| +0.5% | +$479 | ﹤0.01% | 1795 |
|
|
2018
Q4 | $101K | Hold |
3,855
| – | – | ﹤0.01% | 1600 |
|
|
2018
Q3 | $88K | Buy |
3,855
+388
| +11% | +$7.92K | ﹤0.01% | 1793 |
|
|
2018
Q2 | $66K | Buy |
3,467
+1,940
| +127% | +$32.4K | ﹤0.01% | 1941 |
|
|
2018
Q1 | $26K | Hold |
1,527
| – | – | ﹤0.01% | 2350 |
|
|
2017
Q4 | $23K | Hold |
1,527
| – | – | ﹤0.01% | 2367 |
|
|
2017
Q3 | $27K | Hold |
1,527
| – | – | ﹤0.01% | 2144 |
|
|
2017
Q2 | $25K | Hold |
1,527
| – | – | ﹤0.01% | 2168 |
|
|
2017
Q1 | $21K | Hold |
1,527
| – | – | ﹤0.01% | 2288 |
|
|
2016
Q4 | $24K | Hold |
1,527
| – | – | ﹤0.01% | 2192 |
|
|
2016
Q3 | $25K | Buy |
1,527
+493
| +48% | +$6.64K | ﹤0.01% | 2154 |
|
|
2016
Q2 | $12K | Hold |
1,034
| – | – | ﹤0.01% | 2324 |
|
|
2016
Q1 | $9K | Hold |
1,034
| – | – | ﹤0.01% | 2391 |
|
|
2015
Q4 | $10K | Hold |
1,034
| – | – | ﹤0.01% | 2388 |
|
|
2015
Q3 | $12K | Buy |
+1,034
| New | +$12.6K | ﹤0.01% | 1820 |
|
Other funds holding VNDA
ACM
Zurich Cantonal Bank's VNDA Position: Q2 2026 in Review
Zurich Cantonal Bank increased its Vanda Pharmaceuticals (VNDA) stake by 81% in Q2 2026, buying an estimated $9.26K and bringing the position to 3,161 shares worth $19.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2482.
Zurich Cantonal Bank first reported a position in VNDA in Q3 2015 and has held it in 33 quarters since. The position peaked at $126K in Q4 2020. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.
- Zurich Cantonal Bank held 3,161 shares of Vanda Pharmaceuticals worth $19.3K as of Q2 2026.
- Zurich Cantonal Bank bought 1,418 Vanda Pharmaceuticals shares in Q2 2026, an estimated $9.26K.
- Vanda Pharmaceuticals made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #2482 holding.
- Zurich Cantonal Bank first reported a position in Vanda Pharmaceuticals in Q3 2015 and has held it in 33 quarters since.
- Zurich Cantonal Bank's Vanda Pharmaceuticals position peaked at $126K in Q4 2020.
- 172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.
Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.